⚠ Tool for educational and informational purposes only — not investment advice or a recommendation to buy or sell. Investing carries risk of capital loss. Read the full disclaimer.
MPT — Medical Properties Trust, Inc.
Last scan (Nov. 5, 2026): price $2.05, RSI 18.18, relative volume 0.87x, MACD ⚪ No, score 46.45.
It's trading below its 200-day average, with an RSI of 18.18 in oversold territory — technically weak, though that can also signal the pessimism is already priced in. Neither the MACD nor a range breakout gives a technical entry signal right now. The analysts' average target price implies +79.0% upside — one of the score's strongest signals.
Price chart
MPT
Price: $1.85 · RSI (14): 15.53 · Rel. volume: 0.92x · Breakout: No
- Current price: ($1.85) — solid white line — the latest available closing price.
- Target price: ($3.67) — dashed green line — average 12-month target price from analysts covering the stock.
- Quarter low: ($1.84) — dotted orange line — the lowest price over the last ~3 months, as a recent support reference.
You can zoom by dragging a rectangle over the chart, or with your mouse wheel. Double-click to reset the view.
What analysts say
MPT
Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 365 facilities and approximately…
- Buy 2
- Hold 3
- Sell 3
Average target price: $3.67 (+98.7% vs. current price) · range $2.0 – $5.0
Healthy Moderate Attention No data
Total market value of the company (price × shares outstanding).
?
P/E (trailing): compares the stock's price with its earnings per share over the last 12 months — how many times that earning is being paid for.
Low: the market pays little for each dollar of earnings. Could be a value opportunity, or a sign the market expects little growth.
?
P/E (forward): same as P/E, but using analysts' estimated earnings per share for the next year.
Same as P/E, using estimated future earnings.
?
PEG: the P/E divided by the expected earnings growth rate — relates how expensive the stock is to how fast it's expected to grow.
Between 1 and 2: the price is roughly aligned with expected growth.
?
Debt/Equity: how much debt the company carries per dollar of shareholder equity — measures how leveraged the balance sheet is.
High leverage: more risk if the cost of debt rises or cash flow drops.
?
Net margin: what percentage of each dollar of revenue ends up as net profit, after all costs.
High margin: usually indicates a strong competitive advantage (brand, scale, technology).
?
Dividend: what percentage of the stock's price is paid out in cash to shareholders each year.
Pays out a portion of its earnings as cash to shareholders on a recurring basis.
?
Beta: how volatile the stock is compared to the overall market (S&P 500 = 1.0).
More volatile than the market: higher potential gain, but also higher potential loss.
General reference ranges, do not vary by sector. Third-party data; may be incomplete. Not investment advice.
💰 Financial Statements (last 3 quarters)
💰 Financial Statements (last 3 quarters)
What this chart shows
- Japanese candlesticks: green when the period's close is higher than its open, red when it's lower.
- Volume: bars colored the same as the candle for that period.
- RSI (14): bottom line with reference levels at 70 (overbought) and 30 (oversold) — the same indicator the daily scanner uses.
- Dotted line on top: the high of the last 20 periods, the same reference the scanner uses to detect breakouts.
Third-party market data, for informational purposes. Not investment advice — read the disclaimer.